Levosimendan Efficacy and Safety: 20 Years of SIMDAX in Clinical Use.

J Cardiovasc Pharmacol · 2020 · PMC7340234 · PMID 32639325

Europe PMC DOI

hedged sentence

0.5300

closest p · 10.6× alpha

0.5300

boldest claim

The sentences

a numerical trendP = 0.53not close (p > 0.1)

No signals were seen for MI [data from 25 studies, RR 0.789, 95% CI (0.522–1.185), P = 0.3], ventricular arrhythmias [data from 9 studies, RR 0.885, 95% CI (0.611–1.281), P = 0.5], or supraventricular arrhythmias [data from 19 studies, RR 1.005, 95% CI (0.782–1.291), P = 0.9], but a numerical trend was seen for hypotension [data from 22 studies, RR 1.389, 95% CI (0.996–1.936), P = 0.53].

also in 1,012 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.